BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Prognosis
61 results:

  • 1. Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients.
    Tadokoro T; Nomura T; Fujita K; Manabe T; Takuma K; Nakahara M; Oura K; Mimura S; Tani J; Morishita A; Kobara H; Ono M; Masaki T
    BMC Gastroenterol; 2024 Apr; 24(1):123. PubMed ID: 38561671
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Sarcomatoid hepatocellular carcinoma: A case report and review of the literature.
    Hu C; Zhao M; Wei Q; Chen Z; Zhao B
    Medicine (Baltimore); 2024 Mar; 103(13):e37641. PubMed ID: 38552058
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeting alk averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma.
    Liu C; Zhou C; Xia W; Zhou Y; Qiu Y; Weng J; Zhou Q; Chen W; Wang YN; Lee HH; Wang SC; Kuang M; Yu D; Ren N; Hung MC
    Nat Commun; 2024 Feb; 15(1):1009. PubMed ID: 38307859
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary tumor resection improves survival benefit of stage IVB cervical carcinoma: a new perspective.
    He Y; Zhang Y; Hu S; Zhang B; Zhang Z; Yao Y; Wang X
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11013-11023. PubMed ID: 37335336
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multisystem alk-positive histiocytosis: a multi-case study and literature review.
    Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
    Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Systematic review on oncologic outcomes on adjuvant endovesical treatment for non-muscle invasive bladder cancer in patients with solid organ transplant.
    Simonet M; Dominguez Gutierrez A; Territo A; Prudhomme T; Campi R; Andras I; Baboudjian M; Hevia V; Boissier R;
    World J Urol; 2022 Dec; 40(12):2901-2910. PubMed ID: 36367586
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Short- and long-term outcomes of laparoscopic versus open liver resection for large hepatocellular carcinoma: a propensity score study.
    Zhang KJ; Liang L; Diao YK; Xie YM; Wang DD; Xu FQ; Ye TW; Lu WF; Cheng J; Shen GL; Yao WF; Lu Y; Xiao ZQ; Zhang JG; Zhang CW; Huang DS; Liu JW
    Surg Today; 2023 Mar; 53(3):322-331. PubMed ID: 35986784
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Neuroblastoma: Essential genetic pathways and current therapeutic options.
    Salemi F; Alam W; Hassani MS; Hashemi SZ; Jafari AA; Mirmoeeni SMS; Arbab M; Mortazavizadeh SMR; Khan H
    Eur J Pharmacol; 2022 Jul; 926():175030. PubMed ID: 35605657
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A single center comparative retrospective study of
    Vaghiri S; Alaghmand Nejad S; Kasprowski L; Prassas D; Safi SA; Schimmöller L; Krieg A; Rehders A; Lehwald-Tywuschik N; Knoefel WT
    Acta Chir Belg; 2023 Aug; 123(4):384-395. PubMed ID: 35317718
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Carbohydrate antigen 125, carbohydrate antigen 15-3 and low-density lipoprotein as risk factors for intraocular metastases in postmenopausal breast cancer.
    Tang J; Yan B; Li GF; Li QY; Liu WF; Liang RB; Ge QM; Shao Y
    Medicine (Baltimore); 2021 Oct; 100(43):e27693. PubMed ID: 34713867
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Safety but Limited Efficacy of Ensartinib in ROS1-Positive NSCLC: A Single-Arm, Multicenter Phase 2 Study.
    Ai X; Wang Q; Cheng Y; Liu X; Cao L; Chen J; Dong X; Zhou J; Fan Y; Huang C; Cui J; Wang Y; Chen G; Ding C; Gao B; Li X; Wang Z; Zhang H; Ding L; Wang Y; Yuan X; Cheng H; Wang T; Lu S
    J Thorac Oncol; 2021 Nov; 16(11):1959-1963. PubMed ID: 34265433
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Coexistence of a secondary STRN-alk, EML4-alk double-fusion variant in a lung adenocarcinoma patient with EGFR mutation: a case report.
    Zeng Q; Gao H; Zhang L; Qin S; Gu Y; Chen Q
    Anticancer Drugs; 2021 Sep; 32(8):890-893. PubMed ID: 34232939
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data.
    Pérez-Segura P; Paz-Cabezas M; Núñez-Gil IJ; Arroyo-Espliguero R; Maroun Eid C; Romero R; Fernández Rozas I; Uribarri A; Becerra-Muñoz VM; García Aguado M; Huang J; Rondano E; Cerrato E; Rodríguez EA; Ortega-Armas ME; Raposeiras Roubin S; Pepe M; Feltes G; Gonzalez A; Cortese B; Buzón L; El-Battrawy I; Estrada V
    Med Clin (Barc); 2021 Oct; 157(7):318-324. PubMed ID: 34154809
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2.
    Yin D; Hu ZQ; Luo CB; Wang XY; Xin HY; Sun RQ; Wang PC; Li J; Fan J; Zhou ZJ; Zhou J; Zhou SL
    Clin Transl Med; 2021 May; 11(5):e409. PubMed ID: 34047479
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
    Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
    IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Long-term Outcomes and Factors Affecting the Survival of Patients with Mucosal Esophageal Squamous Cell Carcinoma.
    Kim GH; Na HK; Ahn JY; Lee JH; Jung KW; Kim DH; Kim HR; Choi KD; Song HJ; Kim YH; Lee GH; Jung HY; Park SI
    Gut Liver; 2021 Sep; 15(5):705-712. PubMed ID: 33462160
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Collision Tumor Composed of an Inflammatory Myofibroblastic Tumor and Adenocarcinoma of the Colon: a Rare Entity.
    Cornacchia C; Rutigliani M; Belli F; Romano N; Serventi A; Fiocca R; Filauro M
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):461-463. PubMed ID: 32919426
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Elevated tumor-to-liver standardized uptake value ratio (TLR) from preoperative
    Wu C; Cui Y; Zhao Y; Chen X; Liao X; Di L; Yin L; Liu M; Wang R
    Eur J Radiol; 2020 Oct; 131():109218. PubMed ID: 32882538
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Serum CEA and CYFRA Levels in alk-rearranged NSCLC Patients: Correlation With Distant Metastasis.
    Numata T; Endo T; Yanai H; Ota K; Yamamoto Y; Shimizu K; Yamada H; Hayashihara K; Okauchi S; Satoh H; Yamada Y; Tamura T; Saito K; Kikuchi N; Kurishima K; Ishikawa H; Watanabe H; Shiozawa T; Hizawa N; Funayama Y; Hayashi S; Nakamura H; Yamashita T
    In Vivo; 2020; 34(4):2095-2100. PubMed ID: 32606188
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.